ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma-Reference-Cited by-同舟云学术

ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma

Published:2015-05 Issue:5 Volume:46 Page:707-715
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Li Man,Cui Xiaobin,Shen Yaoyuan,Dong Hongchao,Liang Weihua,Chen Yunzhao,Hu Jianming,Li Shugang,Kong Jing,Li Hongan,Zhao Jin,Li Feng

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference34 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90;Ke;Int J Cancer,2002

3. Esophageal cancer: a review and update;Layke;Am Fam Physician,2006

4. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas;Ma;Carcinogenesis,2005

5. Cytological screening and 15 years' follow-up (1986-2001) for early esophageal squamous cell carcinoma and precancerous lesions in a high-risk population in Anyang County, Henan Province, Northern China;Wang;Cancer Detect Prev,2005

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Squamous Neoplastic Precursor Lesions of the Esophagus;Gastroenterology Clinics of North America;2024-03

2. Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer;Nature Communications;2023-08-08

3. Inheritance of Monogenic Hereditary Skin Disease and Related Canine Breeds;Veterinary Sciences;2022-08-15

4. Defective expression of C20orf54 in esophageal dysplasia: a possible biomarker of esophageal carcinoma for early detection;World Journal of Surgical Oncology;2022-05-12

5. FGF19 Is Coamplified With CCND1 to Promote Proliferation in Lung Squamous Cell Carcinoma and Their Combined Inhibition Shows Improved Efficacy;Frontiers in Oncology;2022-04-07